| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹14,888 | -0.75% | |
| 6 months | ₹30,000 | ₹29,011 | -3.30% | |
| 1 year | ₹60,000 | ₹57,469 | -4.22% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| SMS Pharmaceuticals Ltd. | Healthcare | Equity | 10.42% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 9.29% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 9.16% |
| Zydus Wellness Ltd. | Consumer Staples | Equity | 8.38% |
| Viyash Scientific Limited | Healthcare | Equity | 8.33% |
| Alivus Life Sciences Ltd | Healthcare | Equity | 7.33% |
| Pfizer Ltd. | Healthcare | Equity | 6.93% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 5.20% |
| ICICI Prudential Life Insurance Company Ltd. | Insurance | Equity | 4.64% |
| HDFC Life Insurance Co Ltd. | Insurance | Equity | 4.12% |
| Aurobindo Pharma Ltd. | Healthcare | Futures | 4.03% |
| HDFC Life Insurance Co Ltd. | Insurance | Futures | 3.97% |
| Medplus Health Services Ltd. | Healthcare | Equity | 3.86% |
| Biocon Ltd. | Healthcare | Futures | 3.82% |
| Concord Biotech Ltd. | Healthcare | Equity | 2.60% |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 2.27% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Futures | 1.88% |
| Reserve Bank of India | Financial | T-Bills | 1.82% |
| ICICI Prudential Life Insurance Company Ltd. | Insurance | Futures | 1.62% |
| Gland Pharma Ltd. | Healthcare | Equity | 1.46% |
| Reserve Bank of India | Financial | T-Bills | 0.92% |
| Reserve Bank of India | Financial | T-Bills | 0.91% |
| Reserve Bank of India | Financial | T-Bills | 0.91% |
| Reserve Bank of India | Financial | T-Bills | 0.91% |
| Reserve Bank of India | Financial | T-Bills | 0.91% |
| Adani Enterprises Ltd. | Services | Equity | 0.61% |
| Reserve Bank of India | Financial | T-Bills | 0.31% |
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +5.3% | -0.8% | +8.2% | +53.8% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 4 | 12 | 6 | -- |